M11.149 Familial chondrocalcinosis, unspecified hand

Name of the Condition

• Familial chondrocalcinosis, unspecified hand

Summary

Familial chondrocalcinosis, unspecified hand is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the hand’s joint tissues, leading to inflammation and potential joint damage. It is a subtype of calcium pyrophosphate deposition disease (CPPD) with a genetic basis, often presenting with recurrent joint pain, swelling, and stiffness in the hand. Diagnosis relies on clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, unspecified hand is caused by genetic mutations that predispose individuals to abnormal calcium pyrophosphate crystal formation in the hand’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Genetic predisposition (family history of CPPD or chondrocalcinosis).
• Advanced age (increased risk with aging, though familial cases may present earlier).
• Metabolic conditions affecting calcium or pyrophosphate levels (e.g., hemochromatosis, hyperparathyroidism).
• Hand trauma or surgery.
• Certain medications (e.g., diuretics) that may alter crystal formation.

Symptoms

• Recurrent joint pain, swelling, and stiffness in the hand.
• Limited range of motion.
• Possible joint deformity over time.

Diagnosis

Diagnosis involves clinical evaluation of hand symptoms, imaging (e.g., X-rays, ultrasound) to detect crystal deposits or joint changes, and sometimes analysis of joint fluid or tissue to identify CPPD crystals. Family history and genetic testing may support a hereditary diagnosis.

Treatment Options

• Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation.
• Colchicine or corticosteroids for acute flare-ups.
• Physical therapy to maintain joint function.
• Management of underlying metabolic conditions if present.

Prognosis and Follow-Up

Prognosis depends on early diagnosis and treatment. Chronic cases may lead to joint damage, but timely intervention can reduce symptoms and slow progression. Regular follow-up with a healthcare provider is recommended to monitor joint health and adjust treatment as needed.

Complications

• Chronic joint pain and stiffness.
• Progressive joint damage or deformity.
• Reduced hand function.

Lifestyle & Prevention

• Protect hands from injury.
• Maintain a healthy diet to support joint health.
• Manage metabolic conditions (e.g., diabetes, thyroid disorders) that may influence crystal formation.
• Avoid excessive hand strain.

When to Seek Professional Help

Seek medical attention if hand pain, swelling, or stiffness persists, worsens, or interferes with daily activities. Prompt evaluation is important to prevent long-term joint damage.

Tips for Medical Coders

Use this code for documented cases of familial chondrocalcinosis affecting the hand when the specific side (right/left) is not specified. Ensure clinical documentation supports the hereditary nature and hand involvement. Verify that no more specific code (e.g., for right/left hand) applies before using M11.149.